INS and Hypoglycemia: GLP-1RAs lower blood glucose by (1) promoting glucose-dependent insulin secretion and suppressing glucagon, thus reducing hypoglycemia risk; (2) slowing gastric emptying to mitigate post-prandial glucose spikes; and (3) suppressing appetite via central nervous system effects, leading to weight loss (38, 39).